Malignant melanoma involving the oral cavity has a highly metastatic potential. Curative surgery is required to resect extensive oral tissues and often results in dysfunction as well as a severe cosmetic deformity in patients with the disease. An alternative technology for the local and sustained delivery of cytokines for cancer immunotherapy has been shown to induce tumor regression, suppression of metastasis, and development of systemic antitumor immunity. However, local immunization of the oral cavity has not previously been studied. In this study, we examined the efficacy of particle -mediated oral gene transfer on luciferase and green fluorescent protein production. The results showed that these proteins were more significantly expressed in oral mucosa than the skin, stomach, liver, and muscle. Using an established oral melanoma model in hamsters, particle -mediated oral gene gun therapy with interleukin ( IL ) 12 cDNA was then conducted. The results indicated that direct bombardment of mouse IL -12 cDNA suppressed tumor formation and improved the survival rate. The skin tumor model created by inoculation of melanoma cells was also significantly inhibited by the oral bombardment of IL -12 cDNA coupled with an irradiated melanoma vaccine administrated to the oral mucosa, compared to treatment with a percutaneous vaccine. IL -12 gene gun therapy, combined with an oral mucosal vaccine, induced interferon -mRNA expression in the host spleen for a long time. These results suggest that immunization of oral mucosa may induce systemic antitumor immunity more efficiently than immunization of the skin and that oral mucosa may be one of the most suitable tissues for cancer gene therapy by means of particle -mediated gene transfer. Cancer Gene Therapy ( 2001 ) 8, 705 -712 
M ucosal malignant melanoma involving the oral cavity is the most aggressive type of oral tumor. As a definitive precursor lesion for mucosal melanoma has not been identified, oral melanomas tend to present at a later stage 1, 2 and are often in a vertical growth phase of disease, which has a highly metastatic potential. Extensive surgical resection of oral melanoma is first selected for clinical treatment, though complete resection always induces a severe cosmetic deformity and dysfunction in patients with the disease. Recent advances in cancer therapy have focused on cytokine -mediated antitumor effects. 3 -5 Anticancer cytokines then allow for development of an immunotherapy directed against the cutaneous melanoma.
Among many cytokines evaluated as antitumor agents, interleukin (IL ) 12 has been shown to have potent immunemediated antitumor activity in many tumor models. 6 -10 IL -12 is a heterodimeric protein ( p35 and p40) that strongly enhances the Th1 -type immune response. 11, 12 The antitumor effects of IL -12 are mediated by activation of cytotoxic T lymphocytes and NK cells 13 -15 and by production of interferon (IFN )-from T cells and NK cells. 8, 16 Based on the biological activity of IL -12, the systemic administration of recombinant IL -12 proteins has indicated superior effectiveness in tumor inhibition in animal models of cancer; however, administration of these proteins has resulted in the death of animals because of severe toxicity. 17, 18 Dose-dependent toxicity with systemic administration of IL-12 has also been reported in patients in the first human trial. 19 Therefore, the topical transfer of cytokine genes may circumvent some of the toxicity of systemic IL -12 delivery and provide adequate local cytokine levels for immune cell activation.
The gene gun is a device for particle -mediated gene transfer, and it can deliver cytokine genes into the tumor microenvironment without any viral vectors. It also has the advantage of being fast, simple, and versatile, independently of cell cycle. 20 -22 Gene gun -mediated in vivo transfection of cytokine genes has recently resulted in regression of tumors in rodent cancer animal models. 10, 23, 24 In this study, we established an oral melanoma model in the hamster. Gene gun therapy with IL -12 cDNA inhibited the rapid growth of local and skin metastatic melanoma in syngeneic -transplanted hamsters and improved the survival rate. Furthermore, treatment of oral mucosa with the gene gun therapy, coupled with an irradiated melanoma as a tumor antigen, significantly inhibited tumor growth in the distant metastatic melanoma model, but this had less of an antitumor effect on skin vaccination than on oral mucosa -mediated vaccination. These findings may provide a useful information for particle -mediated gene transfer via oral mucosa in local and metastatic lesions of melanoma.
MATERIALS AND METHODS

Hamsters, cells, plasmids, and recombinant IL -12 proteins
Male 6 -week -old Syrian ( Golden ) hamsters were purchased from SLC (Shizuoka, Japan ) and maintained in the Experimental Animal Center of Jichi Medical School.
The melanoma cell line, RPMI 1846, was obtained from the American Type Culture Collection (Rockville, MD ) and was maintained in McCoy's 5a medium supplemented with 20% fetal calf serum, 100 mg / mL streptomycin, and 100 international units/mL penicillin. The cultures were kept at 378C in a 5% CO 2 and 95% air humidified atmosphere. Cells in exponential growth were harvested by trypsinization and washed twice in phosphate -buffered saline ( PBS ). Cell viability was determined by Trypan blue dye exclusion.
The mouse IL -12 expression plasmid, pCAGGS -IL -12, 25 was kindly provided by S. Wolf ( Genetic Institute, Cambridge, MA ), and contained both IL -12 p35 and p40 cDNA driven under a chicken -actin gene promoter. The Renilla reniformis luciferase expression plasmid, pRL -TK, was obtained from Promega ( Madison, WI ), and its gene is driven under a herpes simplex virus thymidine kinase (HSVtk ) promoter. The expression construct for an enhanced type of mutant in the green fluorescent protein (GFP ) gene, phGFP -105 -C1, 26 driven under a cytomegalovirus promoter, was kindly donated by T. Osumi ( Himeji Institute of Technology, Hyogo, Japan ). Large-scale preparation of plasmid DNA was performed by the alkaline lysis method, and closed circular plasmid DNA was purified by equilibrium centrifugation in CsCl -ethidium bromide gradients.
Recombinant murine IL-12 proteins were purchased from R&D Systems (Minneapolis, MN ). IL -12 preparations were diluted in PBS containing 0.1% bovine serum albumin.
Particle -mediated gene delivery
The Helios 2 gene gun system (Bio -Rad Laboratories, Tokyo, Japan ) was used according to the instruction manual of the manufacturer. Plasmid DNA was precipitated onto 1.6 m gold particles as described in a previous report. 27 The suspension of plasmid DNA -coated gold particles was introduced into a Tefzel 1 tube (Bio-Rad Laboratories ) placed on a flow of nitrogen ( 0.4 mL /min ) for 15 minutes. The tube was then cut into 1.2-cm -length cartridges and stored in a container with silica gel at À 208C. One milligram of gold particles contained 2.0 g of plasmid DNA, resulting in delivery of 1.0 g of DNA per shot.
Luciferase assay
The expression plasmids of phGFP -105 -C1 and pRL -TK were mixed to a ratio of 1:9 and then were precipitated onto gold particles as described above. The expression area of the introduced GFP gene was easily visualized under an excitation light of 489 nm and punched out with a 6 -mm diameter at the indicated period after transfection. The luciferase activity was measured using a Luciferase Reporter assay system ( Promega). Each assay was independently repeated several times, and the average value was indicated. The activity was dependent on the incubation time and protein concentration used for the assay.
Oral melanoma model and in vivo treatment protocol
For the oral melanoma model, hamsters were injected in the cheek pouch mucosa with 1Â10 5 RPMI-1846 melanoma cells in 100 L of PBS. Expression vectors were introduced into in vivo oral mucosa overlying the target tumor via a 250 -psi (1 psi =6890 Pa ) blast of the gene gun on days 5 and 7 after tumor implantation. There were two groups of gene gun -treated hamsters, including those treated with IL-12 and those with control GFP expression vectors, and tumor growth was monitored two or three times per week by measurement of two perpendicular tumor diameters. Then, tumor weight was evaluated using the following equation: [ tumor weight =( the length in millimeters )Â(the width in millimeters ) 2 /2 ]. This is an approximation of the volume of an ellipsoid, and it can be considered a valid estimate of tumor weight assuming unit density.
For IL -12 protein therapy, hamsters were injected submucosally in the oral tumor with recombinant IL-12 proteins ( 0.5 g /hamster in 0.1 mL PBS ) on days 5 and 7 after tumor implantation. For control treatment, hamsters were injected with PBS containing 0.1% bovine serum albumin.
For the skin melanoma model, hamsters were shaved in the abdominal area and injected intradermally with 1Â10 5 RPMI-1846 cells. For melanoma vaccination, RPMI-1846 cells were irradiated with 60 Gy under -ray, and 1Â10 5 irradiated cells were then inoculated into the cheek pouch mucosa or shaved back skin. Hamsters were treated by means of the same procedure as mentioned above. Hamsters were anesthesized with ketamine and xylazine for all procedures.
IFN -mRNA expression in spleen by reverse transcription polymerase chain reaction ( RT -PCR )
Total RNA was extracted from the spleens of hamsters with or without gene gun treatment using an RNeasy Mini Kit ( Qiagen, Chatsworth, CA ). One microgram of total RNA was reverse -transcribed using a reverse transcriptase SuperScript II (Gibco, Gaithersburg, MD ) with random hexanucleotides at 458C for 60 minutes. PCR was then performed with the following primers: IFN -sense, The expression plasmids of phGFP -105 -C1 and pRL -TK were mixed to a ratio of 1:9 and then were transfected into the oral mucosa using a Helios gene gun at 250 psi. The expression area of introduced GFP gene was visualized under excitation light of 489 nm, and an area 6 mm in diameter was punched out at the indicated period after transfection. The luciferase activity was then measured as described in Materials and Methods. Expression of luciferase in vivo peaked at 1 day postbombardment by the Helios gene gun and decreased to baseline by 3 and 7 days. Error bar, SD ( n = 8 ). B: Correlated expression between luciferase and GFP genes. Relative luciferase activity at 1 day postbombardment of the gene gun was correlated with GFP expression grade ( y = 4Â10 6 x À 3Â10 6 , r 2 = 0.86 ). Expression grade of GFP was determined as the indicated lower panel ( grades 1 -3 ). Error bar, SD ( n = 6 ). C: Luciferase activity in various organs. Relative luciferase activity at 1 day posttransfection was higher in oral mucosa and skin than liver, muscle, spleen, and stomach. Relative luciferase activity was 3 -fold greater in oral mucosa than skin ( P < .05 ). Error bar, SD ( n = 6 ).
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Statistical analysis
Data were presented as mean ± SD. Statistical differences between the two groups were evaluated using the unpaired Students' t test. The survival rates were analyzed by means of the Kaplan -Meier method and the log rank test. The calculations were performed by means of the software Statview 2 ( Abacus Concepts, Berkeley, CA ). P values less than .05 were considered significant.
RESULTS
Gene expression in oral mucosa of hamster
To examine whether particle -mediated gene transfer was effective in treating the oral mucosa in the hamsters, we transfected the tissue in normal hamsters with luciferase and GFP reporter genes driven by an HSV-tk and a CMV promoter, respectively. Expression of luciferase in vivo peaked at 1 day postbombardment by the Helios gene gun and decreased to baseline at 3 and 7 days ( Fig 1A ) . GFP expression was also easily detected under the 489-nm excitation light, and a section of the expressing area 6 mm in diameter was punched out for further measurement of luciferase activity. The relative fluorescent intensities showed a correlation between luciferase and GFP expression level (Fig 1B ) . Gene gun techniques sometimes cause mechanical damage due to the shot of the microcarriers, especially with pressurized gas-accelerated particles. 25, 27 Therefore, it is essential that an optimum pressure be selected for successful in vivo gene transfer in relation to the avoidance of tissue damage. Based on the expression levels of the transfected GFP gene in oral mucosa with various gas pressures, an optimum pressure of 250 psi was established ( data not shown ).
Furthermore, we also examined the delivered luciferase activity in various organs. Luciferase activity was easily detected in the oral mucosa and skin. Relative luciferase activity was 3-fold higher in oral mucosa than skin (Fig 1C ) . However, the level of this activity in the stomach, spleen, muscles, and liver was significantly low. Notably, GFP expression was observed in the epithelial cells, although gold particles were microscopically present in the submucosa or dermis (data not shown). These results suggest that gene gun -mediated transfection is useful for oral mucosa as well as skin.
Local antitumor effect of gene gun treatment using IL -12 cDNA in oral melanoma model RPMI-1846 melanoma cells (1Â10 5 cells ) were implanted into the cheek pouch mucosa of syngeneic hamsters, resulting in the successful establishment of an oral melanoma model at 5 days postimplantation. Local effects of gene gun -mediated IL-12 cDNA were then determined. Oral melanomas in the hamster model were treated using a gene gun at days 5 and 7 after the tumors were inoculated. As shown in Figure 2A , the gene gun therapy with IL -12 cDNA resulted in significant suppression of oral melanomas at 14 days after tumor challenge, compared with topical submucosal injection of recombinant IL -12 heterodimeric proteins. We noted that neither obvious side effect nor body weight loss was observed in the course of the gene gun treatment. However, control treatment with GFP expression plasmid led to the development of large tumors in the cheek pouch of the hamsters. The antitumor effect of IL-12 cDNA also contributed to an improvement of the survival rate, and the lifespan in the IL -12 -treated hamsters was significantly increased (Fig 2B ) . These results suggest that gene gun therapy with IL -12 cDNA could be useful for the treatment of oral melanoma.
Systemic effect of the IL -12 gene gun treatment on distant metastatic foci
Particle -mediated in vivo delivery of the IL -12 gene in an expression plasmid has also been evaluated for systemic antitumor activity. 10 In the present study, we also observed an initial preliminary finding that the opposite side of the oral melanoma in the cheek pouch was obviously suppressed after the other side was topically treated with the IL -12 cDNA. Then, we examined the systemic effect of the oral gene gun treatment on implanted skin melanomas as a distant metastatic model. The same gene gun protocol was employed at days 5 and 7 after the tumors were implanted. As shown in Figure 3A , the gene gun therapy with IL -12 cDNA resulted in marked regression of skin melanomas, compared with control bombardment with GFP cDNA. Furthermore, these results were also supported by the survival rate (Fig 3B ) . Notably, hamsters in complete regression of melanoma survived for longer than 60 days.
Furthermore, in this series of experiments, we also tested an irradiated melanoma vaccine to see whether it had a greater immunological effect. The therapy with IL -12 cDNA alone showed almost the same effect as that involving the injection of an irradiated melanoma vaccine into the oral mucosa. However, the skin tumors were completely inhibited by the gene gun therapy using IL-12 cDNA coupled with an irradiated melanoma vaccine injected into the oral mucosa. These results indicate that the gene gun therapy using IL -12 cDNA, coupled with cancer vaccines, may more efficiently induce a systemic antimelanoma effect than IL-12 cDNA alone.
However, gene gun therapy combined with skin vaccination did not achieve the same results as that of oral immunization (Fig 3C ) . This result also suggests that gene gun therapy using IL -12 cDNA, coupled with oral cancer immunization, can more efficiently induce a systemic antimelanoma effect.
Long -lasting Th1 predominance in IL -12 gene gun treatment with oral cancer vaccination
We also evaluated whether IFN -production could be enhanced in vivo after treatment via IL -12 cDNA bombardment with or without an irradiated melanoma vaccination. RT-PCR analysis was performed from total RNA of spleens in various experimental groups at 40 days after implantation of melanoma cells. Figure 4A shows a representative result of RT-PCR analysis. The highest expression level of IFN -mRNA was observed in the group of hamsters treated with gene gun therapy using IL -12 cDNA combined with oral immunization ( relative photointensity indicated 0.32: Figure 4B cDNA alone showed a basal expression level of IFNmRNA ( 0.09-0.11: lanes 1 -4) . These results suggest that the IL-12 gene gun treatment, coupled with cancer vaccination injected into the oral mucosa and skin, may contribute to maintaining Th1 -predominant antitumor immunity for a long time and that the antitumor activity resulting from vaccination into the oral mucosa, when coupled with IL-12 gene gun treatment, is higher than that resulting from skin -mediated immunization.
DISCUSSION
In this study, we established a therapeutic model using gene gun therapy to treat oral melanoma in hamsters. Although gene gun-mediated in vivo transfer of cytokine genes has resulted in suppression of tumors in rodent cancer animal models, a therapeutic model for treating oral cancer has not previously been developed. Cheek pouch of hamster can be easily pulled out of the oral cavity, in which a nozzle of gene gun can be easily accessed. Therefore, hamster cheek pouch appeared to be suitable for an oral cancer therapy model using gene gun.
Because the efficacy of transfection is limited in area and depth, gene gun therapy appears unsuitable for delivery of therapeutic genes such as antisense, suicide, or tumorsuppressor genes. However, gene gun technology has a great potential in the field of gene immunization and DNA vaccination against infectious agents and tumors. Only a few studies about particle -mediated gene transfer of cytokine cDNA into oral mucosa (e.g., GM -CSF, IL -2, and IL -6 ) have been reported, 28 but the expression and general safety of transferred genes have only been evaluated in one case. In the present study, we demonstrated the expression efficiency of luciferase and GFP genes in oral mucosa and the successful treatment of oral melanoma using the particlemediated IL -12 cDNA transfer method.
IL-12 gene therapy represents an important advance in immunotherapy in providing an antimetastatic effect as well as local efficiency. Many therapeutic processes in immunology are based on the systemic administration of cytokines, which, unfortunately, is often accompanied by severe complications. 17, 18 Local administration of IL -12 into a tumor or peritumor site can prevent these side effects and result in systemic antitumor immunity. 7, 8, 10 However, most therapies based on biological effects depend on continuous exposure of tumor cells to the cytokines, which is difficult to achieve in administration of recombinant cytokine proteins. In the present study, we did not observe severe inflammation or ulceration of the cheek pouch of hamsters for several days following transfection with the IL -12 expression plasmid. No other toxicity was observed, underscoring the safety of this therapeutic modality as well as of previous uses of cytokine gene therapy. Therefore, topical treatment with the IL -12 gene could circumvent some of these complications and provide adequate local levels for immune cell activation.
IL-12 also acts as a differentiation factor on CD4 + (T helper, Th0 ) cells, promoting their specialization into Th1 cells by priming T cells for IFN -production and by enhancing the ability of differentiated Th1 clones to produce IFN -. 11, 12 In this study, it has been shown that the expression level of particle -mediated transferred genes is higher in the oral mucosa than any other tissues. Therefore, local administration of IL -12 cDNA into the oral mucosa using gene gun efficiently directed the immune response to the Th1 -type inducing the production of IFN -.
In the group treated with IL -12 cDNA, coupled with cancer vaccination into the oral mucosa, INF -mRNA expression in the spleen was maintained for a long time. Administration of IL -12 combined with a vaccination appears to contribute to long -lasting Th1 -mediated antitumor immunity. IL -12 is synthesized mainly by activated mononuclear phagocytes and dendritic cells. IL-12 is a potent and required inducer of efficient IFN -production by T cells as well as NK cells. 29, 30 Although it has yet to be elucidated why vaccination of the oral mucosa is more effective than skin immunization, it is likely to be related to the function of unique immune effector cells in the oral mucosa, such as Langerhans cells 31, 32 and the -type of T cells 33, 34 -cells that play a key role in the immune surveillance system against foreign antigens. Some cytokines, including IL -12, have been reported to enhance the immune function in these cells, 35 but these cells might simply have a great advantage in generating an antigenspecific immunological memory.
Recently, it has been shown that the antimetastatic potential of IL -12 gene therapy is independent of the induction of IFN -synthesis. This was the case for a shortterm antimetastatic effect. 36 For a long -term effect, however, IL -12 cDNA -induced IFN -production seems to be essential because it has been shown that IFN -profoundly enhances the ability of monocytes and polymorphonuclear neutrophils to produce IL -12. 37 Furthermore, addition of tumor antigens could provide a benefit to the tumor-specific immunological memory. Many antigens to melanomas have been identified in human and rodent animals, 38 -40 and combination therapy with these antigens and cytokines by using a gene gun might be applied in clinical settings.
This study proposes that immunization of the oral mucosa may more efficiently induce systemic antitumor immunity than skin immunization and that oral mucosa may be one of the most suitable tissues for cancer gene therapy by particlemediated gene transfer. Therefore, these results may provide not only a new therapeutic strategy for oral melanomas, but also an efficient and safe immunogene therapy for distant metastatic melanomas by using a particle -mediated IL-12 gene transfer coupled with an anticancer vaccination.
